AMA Suggests Ways to Encourage Use of Patient Portals

Share this content:
AMA Suggests Ways to Encourage Use of Patient Portals
AMA Suggests Ways to Encourage Use of Patient Portals

THURSDAY, July 16, 2015 (HealthDay News) -- Measures can be taken to encourage patients to use patient portals to help ensure practices meet current Stage 2 meaningful use requirements, according to an article published by the American Medical Association (AMA).

Physicians must provide online access to at least one-half of their patients in order to meet current Stage 2 requirements, with health information being made available to the patient within four business days of becoming available to the physician. According to the current standard, at least 5 percent of patients must use this service, although this standard may be loosened.

Several measures can be taken to encourage patients to use the portal to access their data. These include training staff on how the portal works, what data are available, and how to connect patients. The portal should be promoted by posting signs in the office and providing fliers on portal benefits. Patients should be encouraged to view or download their health information. Following a patient visit, having a staff member show patients how to set up an account and access data at a designated computer station or tablet in a public area of the office can encourage patients to use the portal.

"The AMA continues to seek less restrictive meaningful use requirements and continues to advocate for changes to the program," according to the article.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »